Market size, growth to 2033 and clinical trials, side by side.
The US is the bigger Omega 3 Fatty Acid market: $1.7 Bn against $328 Mn in 2023, about 5.3 times as large.
Canada grows faster: 7.4% a year, against 5.4%. The gap still grows from $1.4 Bn to $2.2 Bn by 2033.
Clinical research: 133 active trials in the US, 38 in Canada.
| Measure | ||
|---|---|---|
| Market size, 2023 | $1.7 Bn | $328 Mn |
| Market size, 2033 projected | $2.9 Bn | $670 Mn |
| Growth a year (CAGR) | 5.4% | 7.4% |
| Money added, 2023–2033 | $1.2 Bn | $342 Mn |
| Share of the world market | 42% | 8% |
| Size rank of 24 countries | #1 | #3 |
| Market per person, 2023 | $5.04 | $7.87 |
| Active clinical trials | 133 | 38 |
| Full report | US report | Canada report |
US Canada · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
The US is the bigger Omega 3 Fatty Acid market: $1.7 Bn against $328 Mn in 2023, about 5.3 times as large.
Canada grows faster: 7.4% a year, against 5.4%. The gap still grows from $1.4 Bn to $2.2 Bn by 2033.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.